https://doi.org/10.5812/ans.87225

The Effect of Four Weeks of Low-Level Laser Radiation (660 nm) on Movement Recovery and Fibroblasts Invasion

authors:

avatar Sogol Yousefi 1 , avatar Vida Hojati 1 , * , avatar Farinaz Nasirinezhad 2 , avatar Fatemeh Ramezani 2 , avatar Atousa Janzadeh 3 , avatar Gholamhasan Vaezi 1

Department of Biology, Damghan Branch, Islamimic Azad University, Damghan, Iran
Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran
Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran
Archives of Neuroscience: Vol.6, issue 4; e87225
published online: September 18, 2019
article type: Research Article
received: December 9, 2018
revised: May 18, 2019
accepted: July 24, 2019

How To Cite Yousefi S, Hojati V, Nasirinezhad F, Ramezani F , Janzadeh A , et al. The Effect of Four Weeks of Low-Level Laser Radiation (660 nm) on Movement Recovery and Fibroblasts Invasion. Arch Neurosci. 2019;6(4):e87225. https://doi.org/10.5812/ans.87225.

Abstract

Background:

Despite the fact that many researches have been done in regards to spinal cord injury (SCI), it remains an undissolved problem that has an effect on the individual’s life and society. It could be due to complicated events that occur after SCI. Inflammation is an important initiator for after SCI events and low-level laser (LLL), which is known as an anti-inflammatory agent.

Objectives:

The aim of this study is the evaluation effects of LLL on the fibroblast invasion, axon number, and functional recovery after SCI.

Methods:

Twenty-four adult male Wistar rats were randomly divided into three groups as control, SCI, SCI + laser. Thirty minutes after SCI that was induced by aneurysm clip LLL irritated for 45 seconds daily and continued for four weeks. Functional recovery by BBB score, fibroblast invasion by H&E, and Axons number by Bielschowsky silver staining was assessed.

Results:

The data indicated LLL therapy improved BBB score, increased axons number, and decreased fibroblasts invasion around cavity comparing to SCI animals (P < 0.001).

Conclusions:

Our result showed that the initiation LLL therapy, in a short time after SCI, could be effective in the reduction of SCI side effects and improved functional recovery.

1. Background

Spinal cord injuries are among the problems that affect the lives of individuals, and it can be said that almost all individuals in the society are at risk of developing it at the same level. spinal cord injury (SCI) is one of the most serious clinical diseases where its prevalence increases year by year. Although its mortality rate has been reduced to less than 5%, the rate of disability caused by it remains high. Among these disabilities, we can mention paraplegia (1, 2). Studies have indicated that trauma to the nervous system can even cause epigenetic changes in the secretion of inflammatory cytokines (3-6). Therefore, not treating and controlling the complications of the spinal cord injuries timely will impose a lot of costs on society. Many attempts have been made to reduce the complications of spinal cord injuries, however, most of them have failed. This is probably due to the complicated responses of the nervous system to the injuries. Despite identifying many of these responses and attempting to moderate them, there is still a little success in improving these complications.

For example, the presence of two primary and secondary phases is identified in the spinal cord, and it is determined that inflammation occurs in the initial phase as well as in the first minutes after the injury, and is the known cause of many complications after the spinal cord injury (7, 8). Thus, at present, the use of anti-inflammatory treatments after SCI are among the first steps in the clinical (9-11).

Low-level laser therapy is one of the anti-inflammatory treatments that its usage to treat disease associated with inflammation has increased in recent years (12-14). Although there is not any complete protocol provided on this topic yet, the conducted researches have indicated that low-level laser is effective in the reduction of post-SCI complications (15-17).

Our previous study indicated that low-level laser (660 nm) radiation for two weeks although improves the movement and reduces tissue complications, it also leads to the entrance of fibroblasts into the lesion, and probably prevents the complete improvement of the lesion (18).

2. Objectives

Following the previous study, this study is designed to investigate whether laser radiation will affect the growth of axons over a longer period of time and will lead to the complication of the entrance of fibroblasts, or not?

3. Methods

In this study, adult male Wistar rats (N = 24) weighing 150 - 180 g were used. All animals were provided from the Empirical Studies Center of Iran University of Medical Sciences. All steps of this research project were conducted at Iran University of Medical Sciences (Iran, Tehran). The animals were kept in standard conditions of an animal house with enough access to water and food, temperatures of 21 ± 3°C, and 12 hours of darkness/light before and during the study. All ethical considerations (code: R.IUMS.REC 1395.95-03-30-26896) were carefully observed when working with animals in accordance with the rules of the National Institutes of Health for the Use of Live Animals.

Animals were randomly divided into three groups.

1. Control group: No intervention was performed on the animals in this group (n = 8).

2. Spinal cord injury group: The animals of this group did not receive any treatment after induction of spinal cord injury (n = 8).

3. Laser therapy group: The animals were exposed to low-level laser radiation for four weeks, 30 minutes after induction of spinal cord injury (n = 8).

3.1. Creating the Model of Spinal Cord Injury

Animals were anesthetized with an intraperitoneal injection of ketamine (80 mg/kg) and xylocaine (8 mg/kg). After shaving the skin of the lumbar vertebrae area and prepping with betadine, a cut was created in the middle line with a scalpel blade. After removing subcutaneous fat and muscles and exposing the lamina of vertebrae, laminectomy was performed at the L1 - T13 level of the spinal cord without damaging the Dura mater. An aneurysm clip, made by FST that provides a force of 20 g/cm2 was used to create a spinal cord injury model by the compressive method. The clip was removed after 1:30 minutes, and then the muscles and skin were stitched with suture 0.3, respectively. Post-surgical care, including the administration of ringer solution to prevent dehydration (3 mL, IP, after surgery), administration of penicillin G for four days after surgery (0.8 mg/100 g, IP), and bladder massage was performed twice a day for all animals. Three days after creating the lesion, the animals with a score higher than three in the BBB test were excluded from the study.

3.2. Functional Recovery Scoring

Each animal was allowed to move freely for four minutes in a circular-shaped area with a diameter of 90 cm and the walls of 24 cm height. Two observers independently (blind) observed the films and rated the animals according to the Basso Beattie and Bresnahan scale (BBB scale) from zero (full paralysis) to 21 (normal stepping). The mean scores of two observers were recorded as the score of each animal. One week after the injury, the BBB scored of animals were recorded. After that, animals were tested for BBB every week for five weeks, and their score was recorded.

3.3. Haematoxylin-Eosin (H&E) Staining

In order to investigate the penetration of fibroblasts around the injury site, the Hematoxylin and Eosin staining was used (19). After staining, an optical microscope (Nikon, magnification × 40) was used to examine lamels and photography. Then, the results of counting fibroblasts were quantified (18).

3.4. Bielschowsky’s Silver Staining

In order to examine the status of the axons after creating the injury and after treatment, this staining, which is based on the adhesion of the silver to the axons, was performed. Therefore, the axon was black in the images (20). Axons around the injury were counted with an optical microscope (Nikon, magnification × 20), and the results were reported quantitatively.

3.5. Low-Level Laser Therapy

In the present study, the diode CW laser with 660 nm wavelength and 100 mW power that was received as a gift from the Heltschl Company (model ME-TL10000-SK) was used. The laser was fixed on a metal rod to maintain the same radiant distance throughout the study. Thirty minutes after removing the aneurysm clip from the site of injury, which was marked before, 5 mm higher and 5 mm lower as well as the mirror of these points on the left and right of the site of injury (9 points 5 mm apart) were radiated with 660 nm low-level laser (LLL) daily. On each point, the laser was radiated for (5 seconds) in different experimental groups (overall 45 seconds). Laser radiation with this method continued for four weeks.

4. Results

4.1. Functional Recovery

Investigating the motion status of animals in four weeks with the BBB test indicated that the induction of injury in the spinal cord causes the reduction of motion score compared to the control group (P < 0.0001, n = 8, df = 8; f = 452.5). The low-level laser radiation, which was radiated from 30 minutes after the induction of the injury to the end of the study, has produced a significant improvement in motion status compared to the SCI group (P < 0.0001); although, it still has a significant difference with the control group (P < 0.0001) (Figure 1).

Effect of four-week low level laser therapy (laser) on functional recovery after spinal cord injury (SCI). Data are expressed as mean ± SEM (n = 8 in each group). ### P < 0.0001 versus control group and *** P < 0.001 versus SCI group.
Effect of four-week low level laser therapy (laser) on functional recovery after spinal cord injury (SCI). Data are expressed as mean ± SEM (n = 8 in each group). ### P < 0.0001 versus control group and *** P < 0.001 versus SCI group.
Figure 1.

Effect of four-week low level laser therapy (laser) on functional recovery after spinal cord injury (SCI). Data are expressed as mean ± SEM (n = 8 in each group). ### P < 0.0001 versus control group and *** P < 0.001 versus SCI group.

4.2. Investigating the Fibroblast Penetration Around the Cavity

The results of Haematoxylin and Eosin staining indicated that injury induction in the spinal cord leads to penetration of fibroblasts around and inside the injury compared to the control group (P < 0.0001, n = 3, Df = 26). The accumulation of fibroblasts around the cavity is recognizable clearly (Figure 2). The presence of fibroblasts has decreased in the group treated with low-level laser radiation for four weeks. In a way that the number of fibroblasts in this group is not significantly different with the control group (P > 0.05), and there is a significant difference with the SCI group (P < 0.0001).

Quantification of fibroblasts penetration by Hematoxylin and Eosin (H&E) staining, four weeks after spinal cord injury (SCI), spinal cord transverse section (20×). Control (A); SCI (B); laser (C); quantitative assay of fibroblast penetration (D). Data are expressed as mean ± SEM. ### P < 0.001, vs control group.
Quantification of fibroblasts penetration by Hematoxylin and Eosin (H&E) staining, four weeks after spinal cord injury (SCI), spinal cord transverse section (20×). Control (A); SCI (B); laser (C); quantitative assay of fibroblast penetration (D). Data are expressed as mean ± SEM. ### P < 0.001, vs control group.
Figure 2.

Quantification of fibroblasts penetration by Hematoxylin and Eosin (H&E) staining, four weeks after spinal cord injury (SCI), spinal cord transverse section (20×). Control (A); SCI (B); laser (C); quantitative assay of fibroblast penetration (D). Data are expressed as mean ± SEM. ### P < 0.001, vs control group.

4.3. Investigating the Status of Axons Around the Injury

The results of a quantitative investigation of Bielschowsky staining indicated that there are few axons around the cavity due to the spinal cord injury in SCI group compared to the control group (df: 3; F = 74.19; n = 3) (P < 0.001) Figure 3. In the group treated with the laser for four weeks, the number of axons around the injury significantly increased compared to the SCI group (P < 0.0001). However, the number of axons in treated animals still has a significant difference with control group, that indicates axonal injury in these groups compared to the control group (P < 0.01).

Quantification of axons by Bielschowsky’s silver staining, four weeks after spinal cord injury (SCI) and low-level laser (LLL). The spinal cord injury has reduced the black spots (axons) and the laser treatment has prevented the loss of axons. Black points indicate axons. Control (A); SCI (B); laser for four weeks (laser 4w) (C) quantitative assay of axons (D) Data are expressed as mean ± SEM. ## P < 0.01, ###P < 0.0001, vs. control group, ***P < 0.01, vs. SCI group. Spinal cord cross-section (20×).
Quantification of axons by Bielschowsky’s silver staining, four weeks after spinal cord injury (SCI) and low-level laser (LLL). The spinal cord injury has reduced the black spots (axons) and the laser treatment has prevented the loss of axons. Black points indicate axons. Control (A); SCI (B); laser for four weeks (laser 4w) (C) quantitative assay of axons (D) Data are expressed as mean ± SEM. ## P < 0.01, ###P < 0.0001, vs. control group, ***P < 0.01, vs. SCI group. Spinal cord cross-section (20×).
Figure 3.

Quantification of axons by Bielschowsky’s silver staining, four weeks after spinal cord injury (SCI) and low-level laser (LLL). The spinal cord injury has reduced the black spots (axons) and the laser treatment has prevented the loss of axons. Black points indicate axons. Control (A); SCI (B); laser for four weeks (laser 4w) (C) quantitative assay of axons (D) Data are expressed as mean ± SEM. ## P < 0.01, ###P < 0.0001, vs. control group, ***P < 0.01, vs. SCI group. Spinal cord cross-section (20×).

5. Discussion

The obtained results in this study indicated that radiation of LLL (660 nm) improved the movement of animals treated with laser, increased the number of axons around the spinal cord, and decreased the entrance of fibroblasts compared to the untreated group, although in the case of motion, difference is still observed compared to the control group.

As mentioned before, SCI complications are divided into two parts of primary and secondary phases that occur shortly after the injury to the spinal cord and lead to apoptosis and necrosis. The secretion and activation of pre-inflammatory factors such as IL1, tumor necrosis factor-alpha (TNF-α) I, and IL-6 begin to increase the minutes after trauma and following it the equilibrium between the production of ROS and antioxidants becomes unbalanced, and oxidative stress happens that lead to cell death (13). In this regard, the increase of ROS is reported around inflammation (13, 21). Apoptosis begins about an hour after the spinal cord injury in the center of the injury, and expands and continues until two weeks later on both rostral and caudal sides of the spinal cord (22). The development of inflammation activates the apoptotic cascade, which leads to the death of sensory and motor neurons and causes pain and disability in movement (21). As also observed in this study, the animals’ motion ability decreased after induction of the SCI. The obtained information from the studies confirms that the treatment should begin in a short limited time. In this study, the radiation of low-level laser (660 nm) started 30 minutes after the induction of injury to prevent the expansion of the injury as much as possible before the beginning of destructive events. Likewise, the improvement of motion observed from the first week of the treatment in this study can be the evidence to the fact that the use of LLL, a well-known therapeutic method to control inflammatory, can be a good alternative in the first line of treatment after SCI (13, 22-25). LLL reduces the secretion of cytokines and inflammatory factors, such as TNF-α, IL-1β, and IL-6 that were increased due to the inflammation (26). Likewise, our previous study indicated that LLL opposes apoptosis by reducing apoptosis through increasing the anti-apoptotic factor Bcl2, Glutathione antioxidant, and decreasing the expression of P2X3 receptors (27). There are some reports of balancing the expression of ROS in stressed cells, which can be another reason for the reduction of apoptosis (28).

In our previous study where LLL therapy was performed for two weeks, it was indicated that although a low-level laser can reduce the expression of Chondroitin sulfate, an impenetrable material forming of a glial barrier, it caused the entrance of fibroblasts into and around the injury (18). After mechanical damage to the spinal cord, the injured part is susceptible for the second phase and is separated from the healthy part by forming a glial wound (29). The fibrotic scar is the part without scar cell that consists of ECM materials. Signals activated after the injury cause the cells that are not normally present in the spinal cord to be infiltrated into the injured area (30). In this regard, the role of fibroblasts and inflammatory cells can be addressed. The fibroblasts enter from the environment and convert into resident cells and introduce inhibitory extracellular matrix (ECM) combinations into the spinal cord. The presence of fibroblasts decreases glial mobility and makes glial wounds more penetrable for the entrance of axons, create physical barrier and reduces the hope for improvement (30, 31). Therefore, the increase in the entrance of fibroblasts, which was observed in the previous study, was a negative point of using LLL. We presumed that this could justify why the cavity did not reduce, which we observed in the LLL group. It seems that an increase in the duration of laser radiation from two weeks to four weeks prevented the entrance of Lymphocytes. As observed in another study, the increase of treatment duration from one week to two weeks significantly reduced the number of lymphocytes (18, 32).

In a short time after the spinal cord injury, the axonal connections are eliminated, the axonal demyelination is created, and axons and arteries are damaged, which totally results in loss of signal transduction and reduction of neurological function. The results of this study also indicated that after SCI, few axons are observed around the injury, while laser radiation prevented the reduction of axons. The previous findings indicated that a number of supra-spinal neurons survive from the damage. These neurons that are in the non-regenerative stage are appropriate candidates for stimulation by treatments that affect nerve tissue regeneration (22). There is the probability that the axons observed around the SCI area after four weeks, are of the axon types that are regenerated by the stimulation of LLL. On the other hand, several studies have indicated that LLL causes regeneration in environmental damage (33-35).

The reduction in the number of fibroblasts and the increase in the number of axons, along with motion improvement, can cause the hope to reduce the complications of spinal cord injury. However, further studies are needed to investigate the effects of LLL on complications such as pain.

5.1. Conclusions

The results of this study indicated that low-level laser (660 nm) radiation that was initiated 30 minutes after SCI, 45 seconds every day for 4 weeks, was able to improve the BBB score and increased the number of axons around the injury, and on the contrary to the previous study, prevented the entrance of fibroblasts. Therefore, there is the probability that the anti-inflammatory effects of LLL are time-dependent, and the treatment should continue until the destruction process exists.

Acknowledgements

References

  • 1.

    Jain NB, Ayers GD, Peterson EN, Harris MB, Morse L, O'Connor KC, et al. Traumatic spinal cord injury in the United States, 1993-2012. JAMA. 2015;313(22):2236-43. [PubMed ID: 26057284]. [PubMed Central ID: PMC4712685]. https://doi.org/10.1001/jama.2015.6250.

  • 2.

    Ma VY, Chan L, Carruthers KJ. Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil. 2014;95(5):986-995 e1. [PubMed ID: 24462839]. [PubMed Central ID: PMC4180670]. https://doi.org/10.1016/j.apmr.2013.10.032.

  • 3.

    Smart C, Strathdee G, Watson S, Murgatroyd C, McAllister-Williams RH. Early life trauma, depression and the glucocorticoid receptor gene--an epigenetic perspective. Psychol Med. 2015;45(16):3393-410. [PubMed ID: 26387521]. https://doi.org/10.1017/S0033291715001555.

  • 4.

    Ramo-Fernandez L, Schneider A, Wilker S, Kolassa IT. Epigenetic alterations associated with war trauma and childhood maltreatment. Behav Sci Law. 2015;33(5):701-21. [PubMed ID: 26358541]. https://doi.org/10.1002/bsl.2200.

  • 5.

    Asadi-Ali Abadi M, Abolghasemi J, Rimaz S, Majdzadeh R, Shokoohi M, Rostami-Maskopaee F, et al. High-risk behaviors among regular and casual female sex workers in iran: A report from Western Asia. Iran J Psychiatry Behav Sci. 2018;12(1). e9744. https://doi.org/10.5812/ijpbs.9744.

  • 6.

    Emery B, Lu QR. Transcriptional and epigenetic regulation of oligodendrocyte development and myelination in the central nervous system. Cold Spring Harb Perspect Biol. 2015;7(9). a020461. [PubMed ID: 26134004]. [PubMed Central ID: PMC4563712]. https://doi.org/10.1101/cshperspect.a020461.

  • 7.

    Ma L, Mu Y, Zhang Z, Sun Q. Eugenol promotes functional recovery and alleviates inflammation, oxidative stress, and neural apoptosis in a rat model of spinal cord injury. Restor Neurol Neurosci. 2018;36(5):659-68. [PubMed ID: 30040768]. https://doi.org/10.3233/RNN-180826.

  • 8.

    Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y, et al. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res. 2004;76(2):265-76. [PubMed ID: 15048924]. https://doi.org/10.1002/jnr.20044.

  • 9.

    Allison DJ, Gabriel DA, Klentrou P, Josse AR, Ditor DS. The influence of chronic inflammation on peripheral motor nerve conduction following spinal cord injury: A randomized clinical trial. Top Spinal Cord Inj Rehabil. 2017;23(4):377-85. [PubMed ID: 29339913]. [PubMed Central ID: PMC5667434]. https://doi.org/10.1310/sci16-00045.

  • 10.

    Caruso MC, Daugherty MC, Moody SM, Falcone RA, Bierbrauer KS, Geis GL. Lessons learned from administration of high-dose methylprednisolone sodium succinate for acute pediatric spinal cord injuries. J Neurosurg Pediatr. 2017;20(6):567-74. [PubMed ID: 28984538]. https://doi.org/10.3171/2017.7.PEDS1756.

  • 11.

    Kucher K, Johns D, Maier D, Abel R, Badke A, Baron H, et al. First-in-man intrathecal application of neurite growth-promoting anti-nogo-a antibodies in acute spinal cord injury. Neurorehabil Neural Repair. 2018;32(6-7):578-89. [PubMed ID: 29869587]. https://doi.org/10.1177/1545968318776371.

  • 12.

    Rosso MPO, Buchaim DV, Kawano N, Furlanette G, Pomini KT, Buchaim RL. Photobiomodulation therapy (PBMT) in peripheral nerve regeneration: A systematic review. Bioengineering (Basel). 2018;5(2). [PubMed ID: 29890728]. [PubMed Central ID: PMC6027218]. https://doi.org/10.3390/bioengineering5020044.

  • 13.

    Uslu MO, Eltas A, Marakoglu I, Dundar S, Sahin K, Ozercan IH. Effects of diode laser application on inflammation and mpo in periodontal tissues in a rat model. J Appl Oral Sci. 2018;26. e20170266. [PubMed ID: 30020350]. [PubMed Central ID: PMC6089569]. https://doi.org/10.1590/1678-7757-2017-0266.

  • 14.

    da Cunha Moraes G, Vitoretti LB, de Brito AA, Alves CE, de Oliveira NCR, Dos Santos Dias A, et al. Low-level laser therapy reduces lung inflammation in an experimental model of chronic obstructive pulmonary disease involving P2X7 receptor. Oxid Med Cell Longev. 2018;2018:6798238. [PubMed ID: 29686745]. [PubMed Central ID: PMC5857317]. https://doi.org/10.1155/2018/6798238.

  • 15.

    da Silva FC, Gomes AO, da Costa Palacio PR, Politti F, de Fatima Teixeira da Silva D, Mesquita-Ferrari RA, et al. Photobiomodulation improves motor response in patients with spinal cord injury submitted to electromyographic evaluation: randomized clinical trial. Lasers Med Sci. 2018;33(4):883-90. [PubMed ID: 29441450]. https://doi.org/10.1007/s10103-018-2447-3.

  • 16.

    Song JW, Li K, Liang ZW, Dai C, Shen XF, Gong YZ, et al. Low-level laser facilitates alternatively activated macrophage/microglia polarization and promotes functional recovery after crush spinal cord injury in rats. Sci Rep. 2017;7(1):620. [PubMed ID: 28377600]. [PubMed Central ID: PMC5428709]. https://doi.org/10.1038/s41598-017-00553-6.

  • 17.

    Veronez S, Assis L, Del Campo P, de Oliveira F, de Castro G, Renno AC, et al. Effects of different fluences of low-level laser therapy in an experimental model of spinal cord injury in rats. Lasers Med Sci. 2017;32(2):343-9. [PubMed ID: 27909916]. https://doi.org/10.1007/s10103-016-2120-7.

  • 18.

    Janzadeh A, Sarveazad A, Yousefifard M, Dameni S, Samani FS, Mokhtarian K, et al. Combine effect of Chondroitinase ABC and low level laser (660nm) on spinal cord injury model in adult male rats. Neuropeptides. 2017;65:90-9. [PubMed ID: 28716393]. https://doi.org/10.1016/j.npep.2017.06.002.

  • 19.

    Llewellyn BD. Nuclear staining with alum hematoxylin. Biotech Histochem. 2009;84(4):159-77. [PubMed ID: 19579146]. https://doi.org/10.1080/10520290903052899.

  • 20.

    Mavroudis IA, Fotiou DF, Adipepe LF, Manani MG, Njau SD, Psaroulis D, et al. Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2010;25(7):585-91. [PubMed ID: 20870670]. https://doi.org/10.1177/1533317510382892.

  • 21.

    Penas C, Navarro X. Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma. Front Cell Neurosci. 2018;12:158. [PubMed ID: 29930500]. [PubMed Central ID: PMC5999732]. https://doi.org/10.3389/fncel.2018.00158.

  • 22.

    Hassannejad Z, Zadegan SA, Shakouri-Motlagh A, Mokhatab M, Rezvan M, Sharif-Alhoseini M, et al. The fate of neurons after traumatic spinal cord injury in rats: A systematic review. Iran J Basic Med Sci. 2018;21(6):546-57. [PubMed ID: 29942443]. [PubMed Central ID: PMC6015255]. https://doi.org/10.22038/IJBMS.2018.24239.6052.

  • 23.

    dos Santos SA, Alves AC, Leal-Junior EC, Albertini R, Vieira RP, Ligeiro AP, et al. Comparative analysis of two low-level laser doses on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation. Lasers Med Sci. 2014;29(3):1051-8. [PubMed ID: 24173911]. https://doi.org/10.1007/s10103-013-1467-2.

  • 24.

    Sergio L, Thome AMC, Trajano L, Mencalha AL, da Fonseca AS, de Paoli F. Photobiomodulation prevents DNA fragmentation of alveolar epithelial cells and alters the mRNA levels of caspase 3 and Bcl-2 genes in acute lung injury. Photochem Photobiol Sci. 2018;17(7):975-83. [PubMed ID: 29922788]. https://doi.org/10.1039/c8pp00109j.

  • 25.

    Yadav A, Verma S, Keshri GK, Gupta A. Combination of medicinal honey and 904nm superpulsed laser-mediated photobiomodulation promotes healing and impedes inflammation, pain in full-thickness burn. J Photochem Photobiol B. 2018;186:152-9. [PubMed ID: 30048845]. https://doi.org/10.1016/j.jphotobiol.2018.07.008.

  • 26.

    Martins DF, Turnes BL, Cidral-Filho FJ, Bobinski F, Rosas RF, Danielski LG, et al. Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes. Neuroscience. 2016;324:485-95. [PubMed ID: 27001179]. https://doi.org/10.1016/j.neuroscience.2016.03.035.

  • 27.

    Janzadeh A, Nasirinezhad F, Masoumipoor M, Jameie SB, Hayat P. Photobiomodulation therapy reduces apoptotic factors and increases glutathione levels in a neuropathic pain model. Lasers Med Sci. 2016;31(9):1863-9. [PubMed ID: 27640000]. https://doi.org/10.1007/s10103-016-2062-0.

  • 28.

    Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337-61. [PubMed ID: 28748217]. [PubMed Central ID: PMC5523874]. https://doi.org/10.3934/biophy.2017.3.337.

  • 29.

    Oyinbo CA. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta Neurobiol Exp (Wars). 2011;71(2):281-99. [PubMed ID: 21731081].

  • 30.

    Orr MB, Gensel JC. Spinal cord injury scarring and inflammation: Therapies targeting glial and inflammatory responses. Neurotherapeutics. 2018;15(3):541-53. [PubMed ID: 29717413]. [PubMed Central ID: PMC6095779]. https://doi.org/10.1007/s13311-018-0631-6.

  • 31.

    Bott K, Upton Z, Schrobback K, Ehrbar M, Hubbell JA, Lutolf MP, et al. The effect of matrix characteristics on fibroblast proliferation in 3D gels. Biomaterials. 2010;31(32):8454-64. [PubMed ID: 20684983]. https://doi.org/10.1016/j.biomaterials.2010.07.046.

  • 32.

    Mojarad N, Janzadeh A, Yousefifard M, Nasirinezhad F. The role of low level laser therapy on neuropathic pain relief and interleukin-6 expression following spinal cord injury: An experimental study. J Chem Neuroanat. 2018;87:60-70. [PubMed ID: 28428016]. https://doi.org/10.1016/j.jchemneu.2017.04.005.

  • 33.

    Takhtfooladi MA, Jahanbakhsh F, Takhtfooladi HA, Yousefi K, Allahverdi A. Effect of low-level laser therapy (685 nm, 3 J/cm(2)) on functional recovery of the sciatic nerve in rats following crushing lesion. Lasers Med Sci. 2015;30(3):1047-52. [PubMed ID: 25595127]. https://doi.org/10.1007/s10103-015-1709-6.

  • 34.

    Takhtfooladi MA, Sharifi D. A comparative study of red and blue light-emitting diodes and low-level laser in regeneration of the transected sciatic nerve after an end to end neurorrhaphy in rabbits. Lasers Med Sci. 2015;30(9):2319-24. [PubMed ID: 26415928]. https://doi.org/10.1007/s10103-015-1813-7.

  • 35.

    Jameie SB, Masoumipoor M, Janzadeh A, Nasirinezhad F, Kerdari M, Soleimani M. Combined therapeutic effects of low power laser (980nm) and CoQ10 on Neuropathic Pain in adult male rat. Med J Islam Repub Iran. 2014;28:58. [PubMed ID: 25405124]. [PubMed Central ID: PMC4219887].